Ann Richmond
16PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Jan 12, 2026
RAS/MEK/PI3K pathway inhibition augments response to CD40 agonism by targeting CD11b+ Bregs thereby overcoming melanoma PD1-resistance.Chi Yan, Weifeng Luo, Jinming Yang
|Jun 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.Blaise R Kimmel, Karan Arora, Neil C Chada
|Dec 17, 2024
A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.Kennady K Bullock, Thomas Hasaka, Emily Days
|Jun 27, 2024
Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer.Kennady K Bullock, Ann Richmond
|Jul 29, 2023
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma.Chi Yan, Caroline A Nebhan, Nabil Saleh
|Mar 03, 2023
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth.J Yang, K Bergdorf, C Yan
Pageof 3
Frequent Collaborators
6 joint publications
Chi Yan
3 joint publications
Sheau-Chiann Chen
3 joint publications
Kennady K Bullock
2 joint publications
Anna E Vilgelm
2 joint publications
Rebecca Shattuck-Brandt
2 joint publications
Christopher A Johnson
2 joint publications
Rami Nayef Al-Rohil
2 joint publications
Nabil Saleh
1 joint publications
K Bergdorf
1 joint publications
Vijaya Bharti
